Morbidity after brachytherapy for prostate adenocarcinoma

被引：0
|
作者：
Crook, J [1 ]
机构：
[1] Univ Toronto, Hlth Network, Toronto, ON, Canada
来源：
MAYO CLINIC PROCEEDINGS | 2004年 / 79卷 / 07期
关键词：
D O I：
10.4065/79.7.945
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：945 / 945
页数：1
相关论文
共 50 条
  • [31] Bowel morbidity after prostate brachytherapy with Cesium-131 assessed by longitudinal EPIC survey
    Beriwal, S.
    Smith, R.
    Vargo, J.
    Benoit, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [32] Relationship between isotope, prostate volume and urinary morbidity following prostate brachytherapy
    Butler, W
    Niehaus, A
    Merrick, G
    Allen, Z
    Galbreath, R
    Adamovich, E
    MEDICAL PHYSICS, 2005, 32 (06) : 1961 - 1961
  • [33] Rectal adenocarcinoma with rectoprostatic fistula following prostate brachytherapy
    Moss, Basil Francis
    Peracha, Amjad M.
    BMJ CASE REPORTS, 2019, 12 (03)
  • [34] Devastating complications following brachytherapy in the treatment of prostate adenocarcinoma
    Moreira, SG
    Seigne, JD
    Ordorica, RC
    Pow-Sang, JM
    Lockhart, JL
    JOURNAL OF UROLOGY, 2004, 171 (04): : 283 - 283
  • [35] Practical considerations in permanent brachytherapy for localized adenocarcinoma of the prostate
    Stone, NN
    Stock, RG
    UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (02) : 351 - +
  • [36] Acute urinary morbidity following transperineal permanent prostate brachytherapy
    Meier, RM
    Bendre, DD
    Freeman, H
    Colburn, G
    Cavanagh, W
    Grimm, PD
    RADIOLOGY, 2000, 217 : 214 - 214
  • [37] Perineal recurrence of prostate ductal adenocarcinoma after transperineal brachytherapy: a case report and literature review
    Fukagai, Takashi
    Hirayama, Kidai
    Morita, Masashi
    Nishimura, Kota
    Yamatoya, Jin
    Noguchi, Tetsuo
    Ogawa, Yu
    Igarashi, Atsushi
    Morota, Madoka
    Kato, Masako
    Oshinomi, Kazuhiko
    Ogawa, Yoshio
    Tsuzuki, Toyonori
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (06) : 612 - 617
  • [38] Effects of segmental Dosimetry on Morbidity in the LDR Brachytherapy for Prostate cancer
    Meyer, A.
    Wassermann, J.
    Fruehauf, J.
    Karstens, J. H.
    von Klot, C.
    Machtens, S.
    Baumann, R.
    Bremer, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 60 - 60
  • [39] Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma
    Ellis, RJ
    Vertocnik, A
    Kim, E
    Zhou, H
    Young, B
    Sodee, B
    Fu, PF
    Beddar, S
    Colussi, V
    Spirnak, JP
    Dinchman, KH
    Resnick, M
    Kinsella, TJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (02): : 362 - 370
  • [40] Influence of preimplant International Prostate Symptom Score on urinary morbidity following prostate brachytherapy
    Gutman, S
    Merrick, G
    Butler, W
    Wallner, K
    Allen, Z
    Galbreath, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S322 - S323
12345